The group’s principle activity is to provide customized research services utilizing proprietary and non-proprietary animal models to screen drugs. The group also provides animal dosing regimens including oral gavage, intratracheal intubation, subcutaneous, intramuscular, intraperitoneal, intradermal, dermal, and intravenous dosing applications. The group operates from United States.
